Company · CIK 0001501697 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
X4 Pharmaceuticals, Inc · XFOR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 SForm 4 → | Aug 13, 4:13 pm EDT | John VolponePresident | 24,576 | $4.44 | $109,228 | 265,305 | −8.48% | |
| Aug 12, 2026 SForm 4 → | Aug 13, 4:10 pm EDT | Adam R CraigExecutive Chairman, Director | 47,436 | $4.44 | $210,829 | 328,651 | −12.6% | |
| Jun 30, 2026 SForm 4 → | Jul 1, 4:23 pm EDT | David KirskeChief Financial Officer | 8,543 | $4.26 | $36,428 | 167,750 | −4.85% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 1, 4:20 pm EDT | Kelly GoldDirector | 110,000 | — | — | 110,000 | — |